Martin-Algarra, S <br/><br/>
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.  [electronic resource] 

 -  Experimental hematology  Dec 1995 
 - 1503-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0301-472X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bone Marrow Transplantation<br/>Cyclophosphamide--therapeutic use<br/>Etoposide--therapeutic use<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use<br/>Histocompatibility<br/>Humans<br/>Leukemia--mortality<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Recombinant Proteins--therapeutic use<br/>Recurrence<br/>Survival Rate<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Whole-Body Irradiation